Bernard Thebaud profile picture

Contact Information

Bernard Thebaud, MD, PhD
613-737-8899 ext 73905
bthebaud@ohri.ca

ORCID logo https://orcid.org/0000-0003-1844-7145

News

Ottawa Hospital researchers awarded $1.85M from Stem Cell Network
May 12, 2022 - Four research teams at The Ottawa Hospital have been awarded a total of $1.85 million to harness stem cells and regenerative medicine to develop new therapies for septic shock, bone and joint conditions, and newborn lung damage, while also ...
Nano therapy for micro-preemies protects lungs, brain in lab study
March 30, 2022 - Very premature babies need extra oxygen and mechanical intervention to breathe, but this damages their lungs, causing a chronic lung disease called bronchopulmonary dysplasia (BPD).
“Cell atlas” could shine light on lung problems in adults and premature babies
April 28, 2021 - Researchers have built a “cell atlas” that shows all the cellular changes that happen during the last stages of lung development.
Experts on call: Stem cells, gene therapy and biotherapeutics
April 22, 2021 - Could biotherapeutics be the key to the next wave of medical breakthroughs? Join this lively discussion to learn how researchers at The Ottawa Hospital are using biological materials like cells, genes and viruses to heal the body and fight disease.
$1M grant to support manufacturing of COVID-19 treatments and vaccines at The Ottawa Hospital and uOttawa
November 6, 2020 - Researchers from The Ottawa Hospital and the University of Ottawa have been awarded $1,050,000 from the Canada Foundation for Innovation to support facilities for manufacturing innovative treatments and vaccines for COVID-19.
Gene therapy for deadly newborn lung disease shows promise in mice
October 26, 2020 - One in a million babies are born with Surfactant Protein B deficiency, a genetic disorder in the lungs that will kill them before their first birthday. The only cure is a lung transplant.
Innovative clinical trial design breathes life into potential cell therapy for lung disease in preterm babies
July 10, 2020 - When it comes to developing medical treatments, it is a long, challenging and expensive road from the research lab to the clinic.Most Canadians give little thought to what goes into the healthcare we receive – we’re happy to get good care when ...
Harnessing stem cells and regenerative medicine to fight COVID-19
April 23, 2020 - Researchers from The Ottawa Hospital and the University of Ottawa have been awarded $490,000 from the Stem Cell Network for two research projects that could help in the fight against COVID-19. These peer-reviewed grants are part of an overall ...
Researchers join the fight against COVID-19
April 2, 2020 - As hospitals and communities band together to fight COVID-19, researchers at The Ottawa Hospital are harnessing their unique expertise and resources to help.
Stem cells may heal lungs of premature babies
March 4, 2020 - Premature babies need extra oxygen and mechanical intervention to breathe but this can damage their lungs, causing a chronic lung disease. A stem cell treatment soon to be tested in clinical trials at The Ottawa Hospital may help heal the lungs ...
Could umbilical cord cell therapy help premature babies? Dr. Bernard Thébaud awarded $638,000 from Stem Cell Network for clinical trial
March 2, 2020 - Dr. Bernard Thébaud and colleagues received $638,000 from the Stem Cell Network with in-kind matching funds from MDTB Cells GmbH to conduct a phase 1 clinical trial of umbilical cord cell therapy for premature babies.
Cell therapy for premature babies: new lab study suggests wider treatment window may be possible
February 19, 2020 - Bronchopulmonary dysplasia (BPD) is a chronic lung disease caused by the breathing equipment that keeps premature babies alive.
$950,000 to help develop stem cell treatments for septic shock, lung injury and muscle degeneration
May 17, 2019 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to four new peer-reviewed research grants from the Ontario Institute for Regenerative ...
$870,000 to help develop stem cell treatments for septic shock, glaucoma, lung injury and muscle degeneration
May 9, 2018 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to five new peer-reviewed research grants from the Ontario Institute for Regenerative Medi
Could stem cells repair the heart, fight infections, mend premature lungs, and heal the brain after stroke?
April 11, 2018 - Ottawa researchers closer to finding out, thanks to $999,900 from the Stem Cell Network Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks
Rejuvenating damaged newborn mouse lungs with stem cells
February 14, 2018 - Dr. Bernard Thébaud and his team have shown for the first time that differentiated human stem cells can prevent lung damage in lab models of bronchopulmonary dysplasia. BPD is a chronic condition caused by the breathing equipment that keeps prematu
Researchers get $558K boost from Heart and Stroke Foundation
June 15, 2017 - Two scientists from The Ottawa Hospital and the University of Ottawa were successful in the Heart and Stroke Foundation’s recent grant-in-aid grant competition. Dr. Baptiste Lacoste was awarded $259,000* to test whether drugs that are already used
Could stem cells fight lung disease in our tiniest patients?
June 15, 2017 - Dr. Bernard Thébaud and his team are hoping to harness stem cells from umbilical cords to treat chronic lung diseases in extremely premature babies like Olivia Eberts. “She’s a miracle because she wasn’t expected to survive,” said her mother, Jamie
Stem cells help newborn rats survive sepsis
May 25, 2017 - Dr. Bernard Thébaud and his team have shown for the first time that stem cells taken from human umbilical cords can help newborn rats survive sepsis. This condition kills half a million babies worldwide every year, and occurs when the immune system
Could stem cells heal premature lungs, fight infections, build muscles and strengthen bones?
May 25, 2017 - Ottawa researchers closer to finding out, thanks to $1.5 million from the Ontario Institute for Regenerative Medicine Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to huma
Learning from the best: researchers study the placenta to learn how to build new blood vessels
April 26, 2016 - In terms of blood vessels, the placenta is one of the most impressive organs in the body. Connecting the fetus to the mother’s uterus, this organ has a massive network of blood vessels that would cover more than 50km – from Ottawa to Kemptville -
Dr. Bernard Thébaud’s team receives $3.2 million to develop stem cell therapy for babies with lung disease
August 19, 2015 - Dr. Bernard Thébaud’s team is one of seven at The Ottawa Hospital recently awarded Foundation Grants by the Canadian Institutes of Health Research. Thébaud’s team has received $3.2 million over seven years to develop three different kinds of ...
Tender Loving Research improving care for premature babies
January 28, 2015 - The latest edition of our Tender Loving Research video blog features Dr. Bernard Thébaud explaining who he does his research for and what inspires him. As a neonatologist and senior scientist, Dr. Thebaud and his team are hoping to harness umbilical
5 big strides to fight lung disease in our tiniest patients
December 4, 2012 - Ottawa — For Ottawa scientist and neonatologist Dr. Bernard Thébaud, even a major paper that answers five significant questions still doesn't seem quite enough in his determined path to get his laboratory breakthrough into the neonatal intensive care
Top stem cell scientist and pediatrician recruited to Ottawa
May 30, 2012 - World-renowned scientist and pediatrician Dr. Bernard Thébaud will soon be in Ottawa to pursue his goal of using stem cells to repair the lungs of premature babies. Dr. Thébaud was recruited by the Ottawa Hospital Research Institute (OHRI), the Chil